Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
Kamal Abu Jabal et al.
Summary: An analysis of 514 Israeli healthcare workers showed that the BNT162b2 mRNA COVID-19 vaccine had similar immunogenicity by ethnicity and sex, but decreased with age. Individuals with prior COVID-19 infection had significantly higher antibody titres compared to those who were naive, regardless of pre-vaccination IgG levels.
EUROSURVEILLANCE (2021)
Article
Infectious Diseases
Validation of a commercially available SARS-CoV-2 serological immunoassay
B. Meyer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Article
Immunology
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Share Paper
